Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-13
Publisher
Hindawi Limited
Online
2014-05-29
DOI
10.1155/2014/203601
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tyrosine Kinase Inhibitor Sorafenib Decreases 111In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma
- (2014) C. H. J. Muselaers et al. JOURNAL OF NUCLEAR MEDICINE
- Glypican-3-Targeted 89Zr PET Imaging of Hepatocellular Carcinoma
- (2014) J. G. Sham et al. JOURNAL OF NUCLEAR MEDICINE
- Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential
- (2014) Lydia Koi et al. RADIOTHERAPY AND ONCOLOGY
- Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry
- (2013) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- ImmunoPET Imaging of Renal Cell Carcinoma with 124I- and 89Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice
- (2013) Alexander B. Stillebroer et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- From Bevacizumab to Tasquinimod
- (2013) Michael T. Schweizer et al. CANCER JOURNAL
- Predictive Biomarkers for Bevacizumab: Are We There Yet?
- (2013) D. Maru et al. CLINICAL CANCER RESEARCH
- 89Zr-PET Radiochemistry in the Development and Application of Therapeutic Monoclonal Antibodies and Other Biologicals
- (2013) Danielle J. Vugts et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Preparation of clinical-grade89Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy
- (2013) Ling Wei et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Placental Growth Factor (PlGF)-Specific Uptake in Tumor Microenvironment of 89Zr-Labeled PlGF Antibody RO5323441
- (2013) T. H. Oude Munnink et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-Bevacizumab PET Imaging in Primary Breast Cancer
- (2013) S. B. M. Gaykema et al. JOURNAL OF NUCLEAR MEDICINE
- Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET
- (2013) Y. Y. Janjigian et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical evaluation of89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys
- (2013) Danielle J Vugts et al. mAbs
- Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma
- (2013) Kristine E. Day et al. MOLECULAR IMAGING AND BIOLOGY
- 89Zr, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges
- (2013) Gabriel Fischer et al. MOLECULES
- Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas
- (2013) Sibaprasad Bhattacharyya et al. NUCLEAR MEDICINE AND BIOLOGY
- Evaluation of 89Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer
- (2013) Aya Sugyo et al. PLoS One
- Treatment of Metastatic Colorectal Cancer with Cetuximab: Influence on the Quality of Life.
- (2013) K. Unger et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Routine Production of 89Zr Using an Automated Module
- (2013) A. Wooten et al. Applied Sciences-Basel
- Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
- (2012) A. Argiris et al. ANNALS OF ONCOLOGY
- Bevacizumab is an active agent for recurrent high-grade glioma, but do we need randomized controlled trials?
- (2012) Patrick G. Morris ANTI-CANCER DRUGS
- Development of a Novel Long-Lived ImmunoPET Tracer for Monitoring Lymphoma Therapy in a Humanized Transgenic Mouse Model
- (2012) Arutselvan Natarajan et al. BIOCONJUGATE CHEMISTRY
- Investigation of Zr(iv) and89Zr(iv) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging
- (2012) François Guérard et al. CHEMICAL COMMUNICATIONS
- Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model
- (2012) A. R. M. van der Bilt et al. CLINICAL CANCER RESEARCH
- The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer
- (2012) Judith R. Kroep et al. CURRENT PHARMACEUTICAL DESIGN
- Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET
- (2012) Saiyada N. F. Rizvi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
- (2012) Jennifer A. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterisation of organic matter associated with groundwater arsenic in reducing aquifers of southwestern Taiwan
- (2012) Wafa M. Al Lawati et al. JOURNAL OF HAZARDOUS MATERIALS
- Immuno-PET of the Hepatocyte Growth Factor Receptor Met Using the 1-Armed Antibody Onartuzumab
- (2012) E. M. Jagoda et al. JOURNAL OF NUCLEAR MEDICINE
- Genetically Encoded Tetrazine Amino Acid Directs Rapid Site-Specific in Vivo Bioorthogonal Ligation with trans-Cyclooctenes
- (2012) Jason L. Seitchik et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Lapatinib and 17AAG Reduce 89Zr-Trastuzumab-F(ab′)2 Uptake in SKBR3 Tumor Xenografts
- (2012) Thijs H. Oude Munnink et al. MOLECULAR PHARMACEUTICS
- Multimodality Imaging of Breast Cancer Experimental Lung Metastasis with Bioluminescence and a Monoclonal Antibody Dual-Labeled with 89Zr and IRDye 800CW
- (2012) Hao Hong et al. MOLECULAR PHARMACEUTICS
- PET imaging with 89Zr: From radiochemistry to the clinic
- (2012) Melissa A. Deri et al. NUCLEAR MEDICINE AND BIOLOGY
- Prostate specific membrane antigen (PSMA): A novel modulator of p38 for proliferation, migration, and survival in prostate cancer cells
- (2012) Yiming Zhang et al. PROSTATE
- Targeting Angiogenesis as a Promising Modality for the Treatment of Prostate Cancer
- (2012) Jianqing Lin et al. UROLOGIC CLINICS OF NORTH AMERICA
- Prostate-specific membrane antigen-based imaging
- (2012) Joseph R. Osborne et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The role of cetuximab as first‐line treatment of colorectal liver metastases
- (2012) Claire Jones et al. HPB
- Synthesis of Phosphine and Antibody–Azide Probes forin VivoStaudinger Ligation in a Pretargeted Imaging and Therapy Approach
- (2011) Danielle J. Vugts et al. BIOCONJUGATE CHEMISTRY
- Modular Strategy for the Construction of Radiometalated Antibodies for Positron Emission Tomography Based on Inverse Electron Demand Diels–Alder Click Chemistry
- (2011) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- Bevacizumab and ovarian cancer
- (2011) Shinya Sato et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Quantitative imaging of 124I and 86Y with PET
- (2011) Mark Lubberink et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies
- (2011) A. G. T. Terwisscha van Scheltinga et al. JOURNAL OF NUCLEAR MEDICINE
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT
- (2011) H. H. Yeh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vitro and in vivo pre-clinical analysis of a F(ab')2 fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers
- (2011) Karen J Wong et al. EJNMMI Research
- VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
- (2010) W. B. Nagengast et al. CANCER RESEARCH
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
- (2010) Thaddeus J. Wadas et al. CHEMICAL REVIEWS
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
- (2010) Bianca A.W. Hoeben et al. INTERNATIONAL JOURNAL OF CANCER
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
- (2010) J. P. Holland et al. JOURNAL OF NUCLEAR MEDICINE
- ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
- (2010) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922
- (2010) W. B. Nagengast et al. JOURNAL OF NUCLEAR MEDICINE
- PET of Hypoxia with 89Zr-Labeled cG250-F(ab')2 in Head and Neck Tumors
- (2010) B. A. W. Hoeben et al. JOURNAL OF NUCLEAR MEDICINE
- Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET
- (2010) Jeff N. Tinianow et al. NUCLEAR MEDICINE AND BIOLOGY
- New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation
- (2010) P Swietach et al. ONCOGENE
- Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
- (2010) Jason P. Holland et al. PLoS One
- 89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft
- (2009) Thijs H. Oude Munnink et al. EUROPEAN JOURNAL OF CANCER
- p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
- (2009) Lars R. Perk et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients
- (2009) P. K.E. Borjesson et al. JOURNAL OF NUCLEAR MEDICINE
- Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
- (2009) E. C.F. Dijkers et al. JOURNAL OF NUCLEAR MEDICINE
- Standardized methods for the production of high specific-activity zirconium-89
- (2009) Jason P. Holland et al. NUCLEAR MEDICINE AND BIOLOGY
- Panitumumab: Human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer
- (2008) Mei Wu et al. CLINICAL THERAPEUTICS
- Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30
- (2008) Lars R. Perk et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Indium-111 capromab pendetide in the management of recurrent prostate cancer
- (2008) Michael J Manyak Expert Review of Anticancer Therapy
- Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
- (2008) H. J.W.L. Aerts et al. JOURNAL OF NUCLEAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now